Quantedge Capital’s Dynavax Technologies DVAX Stock Holding History

Quantedge Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-52,900	Closed	-$525K	–	79
2025 Q3	$525K	Buy	+52,900	New	+$551K	0.29%	43

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantedge Capital's DVAX Position: Q4 2025 in Review

Quantedge Capital sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 52,900 shares — an estimated $525K sold.

Quantedge Capital first reported a position in DVAX in Q3 2025 and held it in 1 quarter. The position peaked at $525K in Q3 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Quantedge Capital reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Quantedge Capital sold 52,900 Dynavax Technologies shares in Q4 2025, an estimated $525K.
Quantedge Capital first reported a position in Dynavax Technologies in Q3 2025 and held it in 1 quarter.
Quantedge Capital's Dynavax Technologies position peaked at $525K in Q3 2025.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Quantedge Capital's 13F filing for Q4 2025, filed 17 Feb 2026.